346P - Phase II study of DHP107 oral paclitaxel in first-line, HER2 negative recurrent/metastatic breast cancer (OPTIMAL study, NCT03315364)
| Autor: | Ahn, J.-H., Lee, K.S., Lee, K.-H., Seo, J.H., KANG, S.Y., Sohn, J., Yang, Y., Park, K.H., Moon, Y.W., Lim, S.T., Yoon, K.E., Cho, H.J., Kim, S.-B. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v124-v124 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|